GD
Grandfield & Dodd Portfolio holdings
AUM
$1.71B
This Quarter Return
+4.32%
1 Year Return
+14.85%
3 Year Return
+57.47%
5 Year Return
+112%
10 Year Return
+284.72%
AUM
$846M
AUM Growth
+$846M
(+4.5%)
Cap. Flow
+$4.76M
Cap. Flow
% of AUM
0.56%
Top 10 Holdings %
Top 10 Hldgs %
27.6%
Holding
188
New
6
Increased
51
Reduced
83
Closed
4
Top Buys
| 1 |
M&T Bank
MTB
|
$4.3M |
| 2 |
Weyerhaeuser
WY
|
$4.3M |
| 3 |
Johnson Controls International
JCI
|
$4.29M |
| 4 |
Gilead Sciences
GILD
|
$3.85M |
| 5 |
Albemarle
ALB
|
$3.24M |
Top Sells
| 1 |
Enbridge
ENB
|
$4.17M |
| 2 |
Emerson Electric
EMR
|
$3.12M |
| 3 |
Autodesk
ADSK
|
$2.15M |
| 4 |
Applied Materials
AMAT
|
$1.58M |
| 5 |
Amgen
AMGN
|
$1.44M |
Sector Composition
| 1 | Technology | 22.45% |
| 2 | Healthcare | 18.78% |
| 3 | Industrials | 11.12% |
| 4 | Consumer Staples | 10.98% |
| 5 | Financials | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Air Products & Chemicals
APD
$65.1B
| $13.2M | 1.56% |
92,181
+280
| +0.3% | +$40.1K |
|
27
CACI
CACI
$10.6B
| $13.2M | 1.56% |
105,447
-3,535
| -3% | -$442K |
|
28
Zimmer Biomet
ZBH
$20.9B
| $13.1M | 1.55% |
102,336
+497
| +0.5% | +$63.8K |
|
29
Verisk Analytics
VRSK
$36.9B
| $12.8M | 1.51% |
151,139
-660
| -0.4% | -$55.7K |
|
|
UN
30
DELISTED
Unilever NV New York Registry Shares
UN
| $12.6M | 1.49% |
228,176
-3,465
| -1% | -$192K |
|
31
Sanofi
SNY
$121B
| $11.4M | 1.34% |
237,568
+2,225
| +0.9% | +$107K |
|
32
eBay
EBAY
$41B
| $11.2M | 1.32% |
319,434
+4,535
| +1% | +$158K |
|
33
Corning
GLW
$58.4B
| $10.7M | 1.26% |
355,217
-7,770
| -2% | -$233K |
|
34
Chevron
CVX
$325B
| $9.63M | 1.14% |
92,284
+380
| +0.4% | +$39.6K |
|
35
Synopsys
SNPS
$109B
| $9.63M | 1.14% |
132,018
-8,060
| -6% | -$588K |
|
|
RDS.B
36
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $9.42M | 1.11% |
173,100
+664
| +0.4% | +$36.1K |
|
37
Walt Disney
DIS
$212B
| $9.22M | 1.09% |
86,811
+14,932
| +21% | +$1.59M |
|
38
Brunswick
BC
$4.12B
| $8.85M | 1.05% |
141,110
+44,670
| +46% | +$2.8M |
|
39
Unilever
UL
$156B
| $8.59M | 1.01% |
158,638
-1,395
| -0.9% | -$75.5K |
|
|
40
M&T Bank
MTB
$30.8B
| $8.47M | 1% |
52,289
+26,543
| +103% | +$4.3M |
|
|
41
Amgen
AMGN
$154B
| $8.44M | 1% |
49,017
-8,358
| -15% | -$1.44M |
|
42
Novartis
NVS
$244B
| $8.15M | 0.96% |
97,672
+3,105
| +3% | +$259K |
|
|
43
Gilead Sciences
GILD
$140B
| $7.21M | 0.85% |
101,903
+54,321
| +114% | +$3.85M |
|
44
Berkshire Hathaway Class A
BRK.A
$1.08T
| $6.88M | 0.81% |
27
+2
| +8% | +$509K |
|
45
Trimble
TRMB
$18.6B
| $6.69M | 0.79% |
187,468
-1,095
| -0.6% | -$39.1K |
|
46
Mondelez International
MDLZ
$79.6B
| $6.53M | 0.77% |
151,272
-1,035
| -0.7% | -$44.7K |
|
|
47
Albemarle
ALB
$9.36B
| $6.17M | 0.73% |
58,485
+30,725
| +111% | +$3.24M |
|
48
Thermo Fisher Scientific
TMO
$183B
| $5.56M | 0.66% |
31,859
-777
| -2% | -$136K |
|
|
49
Emerson Electric
EMR
$73.6B
| $5.27M | 0.62% |
88,329
-52,299
| -37% | -$3.12M |
|
50
GE Aerospace
GE
$291B
| $4.76M | 0.56% |
176,369
-700
| -0.4% | -$18.9K |
|